Glycosaminoglycans and the regulation of blood coagulation.
about
Inflammation and haemostasisPathophysiology of heparan sulphate: many diseases, few drugsPolysaccharide nanosystems for future progress in cardiovascular pathologiesEvidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagenConformation of heparin pentasaccharide bound to antithrombin IIIA computational approach for deciphering the organization of glycosaminoglycansGlycomics approaches for the bioassay and structural analysis of heparin/heparan sulphatesChemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry.Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.Determination of sulfate ester content in sulfated oligo- and poly-saccharides by capillary electrophoresis with indirect UV detection.Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: a review.Incorporation of Sulfated Hyaluronic Acid Macromers into Degradable Hydrogel Scaffolds for Sustained Molecule Delivery.Vascular protease receptors: integrating haemostasis and endothelial cell functions.Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells.Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials.Docking server for the identification of heparin binding sites on proteins.Molecular diversity of heparan sulfate.Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function.Antithrombotic therapy in cardiac embolism.Biochemical defects of mutant nudel alleles causing early developmental arrest or dorsalization of the Drosophila embryoProtein C pathway in sepsis.A strategy for rapid sequencing of heparan sulfate and heparin saccharides.Simulated surface-induced thrombin generation in a flow fieldMicrobial adherence to and invasion through proteoglycansVisualization of in vivo thromboprophylactic and thrombolytic efficacy of enoxaparin in laser-induced vascular endothelial injury model using multiphoton microscopyNew antithrombin-based anticoagulants.Heparan sulfate-dependent enhancement of henipavirus infection.New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology.Bikunin present in human peritoneal fluid is in part derived from the interaction of serum with peritoneal mesothelial cellsA heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities.Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in ratsPeriodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung.Heparin protection against Fe2+ -and Cu2+ -mediated oxidation of liposomes.The chemical neurobiology of carbohydratesHeparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation.Identification of functional endothelial protein C receptor in human plasma.Engineering nanoassemblies of polysaccharides.Thrombin inhibitors from different animals.
P2860
Q26823258-C64E09A8-DED7-477E-B63C-834AA7775AF8Q26823840-578946B7-6CEC-428B-9AAA-CD121A6EDA5EQ27025494-B1E1A2C8-296C-496E-BCAA-E4E88B10D866Q28215340-DE1E19BC-5E59-4021-9C28-7E8A3046C491Q28360842-23946837-A8FC-4F7C-8FFB-A90F0818E42CQ28473002-F569A608-449D-45AA-A1DA-7A59DAEC593BQ30437948-28B5ACA9-41DD-4262-9527-7927784EDA1DQ30857874-16AB8158-A937-4A12-A62E-ADFD197B7256Q31074211-6340054F-494E-412A-BAE2-760E93DACB95Q32068517-CEF63987-816E-423A-B821-B3C86F70D802Q33230192-B2A25F58-5C45-4E91-9B78-D9F99D5AEA9EQ33641833-6B29B282-3FDC-469F-93E9-085781580951Q33696717-CAE2E0B5-E011-4A59-83ED-B455A1A257E7Q33768686-05F3C735-9F63-456F-81AF-640B7CF9CEE8Q33843585-608E1319-19BB-462B-8DC5-8C8BA3DA043CQ34071225-FEEE6FB1-F136-49F8-94A2-5B569DC2A9C2Q34192459-98BE46B8-AB60-4D76-854C-151527A76E0DQ34285002-30CEFF41-CE55-47AA-834C-2C4CB07010DFQ34310374-9653B731-22F5-4402-8390-31627546235CQ34361094-CABEC822-6D30-4E1F-839C-7109A486219CQ34362901-E26F4BA1-76D3-47E7-AFC7-2192364AE2DCQ34608575-8F1E553A-23EB-493D-975F-7A5BE01DD256Q35055016-5FB428B7-CA0A-4C6C-96C9-5F1F0072F36EQ35059120-CE59BEB9-F845-4827-902B-28164ECE11ADQ35106714-BB8059C9-5B54-441C-A597-AA4648DB5AAAQ35533138-0E6998CB-1211-42C2-B64B-499E8A4AD859Q35574330-515DA47A-CA83-4E57-B767-736FA789582BQ35620257-F7C4FF34-E1A2-405C-B66D-BA3BF21DDE32Q35677600-225F77D8-9069-4C7F-A834-33F31F4D4A1DQ35682219-8D8665DE-6807-4767-9F88-85A3D1A03A53Q35753565-640E4346-73FA-456A-B370-E2434266E1D3Q36020898-819A8256-6701-4C7A-96F5-4A3599CCA627Q36309004-9AF1964B-B324-4677-9E22-4DCBFBDF894CQ36644517-2B2E3A04-9DC2-4951-9883-C8184D733B10Q36833327-3A5A5ED9-1BAB-4138-9D4A-494A6505D6A2Q37152815-99929794-889C-480A-805D-6927C4CC19A6Q37263145-AA8674E9-8D95-4758-BEEE-F0FF301AB9F4Q37370139-0DE8013B-3C75-4481-A268-49A7AB5E8699Q37769174-E70873D9-1551-4381-ADBF-FB69C2C3FDB5Q37803133-8975AE69-02D7-4E1B-A44B-E05D583D93FF
P2860
Glycosaminoglycans and the regulation of blood coagulation.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Glycosaminoglycans and the regulation of blood coagulation.
@en
type
label
Glycosaminoglycans and the regulation of blood coagulation.
@en
prefLabel
Glycosaminoglycans and the regulation of blood coagulation.
@en
P2860
P356
P1433
P1476
Glycosaminoglycans and the regulation of blood coagulation.
@en
P2093
P2860
P304
P356
10.1042/BJ2890313
P407
P478
289 ( Pt 2)
P577
1993-01-01T00:00:00Z